Fast-acting impotency drug outpaces rivals: study

[steven johnson]

A new faster acting erectile dysfunction remedy may soon be on the market in 2012.

Patients with established erectile dysfunction had successful intercourse within 15 minutes of dosing were successful 72% of the time with 200 mg of avanafil compared to 29% of the patients on placebo. ED affects an estimated 52 percent of men between the ages of 40 and 70. In the US, at least 10 to 20 million men and world wide 150 million men are thought to be affected with erectile dysfunction.

VIVUS Announces Additional Results of Phase 3 avanafil Study

(AFP) – 13 hours ago

WASHINGTON — Biotech firm Vivus unveiled a would-be player Monday in the 3.7-billion-dollar erectile dysfunction market: avanafil, effective in just 15 minutes, far faster than blockbuster rivals Viagra and Cialis.

Knowing avanafil acts in 15 minutes and lasts the length of a sexual encounter should be huge pluses for the drug in this highly lucrative market, said Dr Charles Bowden with Vivus.

The company is eyeing a market launch in early 2012.

Pfizer, which makes Viagra, says its drug acts within 30 minutes to an hour after it is taken. Cialis, made by Eli Lilly, starts working from 30 minutes to six hours after ingestion. A third competitor, Levitra, acts starting between 25 and 60 minutes after it is taken.

Fast-acting impotency drug outpaces rivals: study

[no_hypocrisy]

1. Wish there was a companion drug to blood pressure medication

to counteract the effects of ED.